The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial

Trials. 2013 Feb 2:14:36. doi: 10.1186/1745-6215-14-36.

Abstract

Background: Malaria transmission is highly heterogeneous in most settings, resulting in the formation of recognizable malaria hotspots. Targeting these hotspots might represent a highly efficacious way of controlling or eliminating malaria if the hotspots fuel malaria transmission to the wider community.

Methods/design: Hotspots of malaria will be determined based on spatial patterns in age-adjusted prevalence and density of antibodies against malaria antigens apical membrane antigen-1 and merozoite surface protein-1. The community effect of interventions targeted at these hotspots will be determined. The intervention will comprise larviciding, focal screening and treatment of the human population, distribution of long-lasting insecticide-treated nets and indoor residual spraying. The impact of the intervention will be determined inside and up to 500 m outside the targeted hotspots by PCR-based parasite prevalence in cross-sectional surveys, malaria morbidity by passive case detection in selected facilities and entomological monitoring of larval and adult Anopheles populations.

Discussion: This study aims to provide direct evidence for a community effect of hotspot-targeted interventions. The trial is powered to detect large effects on malaria transmission in the context of ongoing malaria interventions. Follow-up studies will be needed to determine the effect of individual components of the interventions and the cost-effectiveness of a hotspot-targeted approach, where savings made by reducing the number of compounds that need to receive interventions should outweigh the costs of hotspot-detection.

Trial registration: NCT01575613. The protocol was registered online on 20 March 2012; the first community was randomized on 26 March 2012.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anopheles
  • Clinical Protocols*
  • Cross-Sectional Studies
  • Data Collection
  • Humans
  • Insecticides / pharmacology
  • Malaria / prevention & control*
  • Malaria / transmission
  • Mosquito Control
  • Outcome Assessment, Health Care
  • Sample Size

Substances

  • Insecticides

Associated data

  • ClinicalTrials.gov/NCT01575613